This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 22/5/1163    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Wheeler, D. Articles by Romero, G. PubMed PubMed Citation Articles by Wheeler, D. Articles by Romero, G.

Regulation of Parathyroid Hormone Type 1 Receptor Dynamics, Traffic, and Signaling by the Na⁺/H⁺ Exchanger Regulatory Factor-1 in Rat Osteosarcoma ROS 17/2.8 Cells

Department of Pharmacology (D.W., J.L.G., A.B., Y.K.K., P.A.F., G.R.), University of Pittsburgh School of Medicine, and the Medical Scientist Training Program (D.W.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261

Address all correspondence and requests for reprints to: Guillermo Romero, University of Pittsburgh School of Medicine, Department of Pharmacology and Medicine, W1345 Biomedical Science Tower, Pittsburgh, Pennsylvania 15261. E-mail: ggr{at}pitt.edu.

The effects of the expression of the Na⁺/H⁺ exchanger regulatory factor-1 (NHERF1) on the distribution, dynamics, and signaling properties of the PTH type 1 receptor (PTH1R) were studied in rat osteosarcoma cells ROS 17/2.8. NHERF1 had a dramatic effect on the subcellular distribution of PTH1R, promoting a substantial relocation of the receptor to regions of the plasma membrane located in very close proximity to cytoskeletal fibers. Direct interactions of NHERF1 with the PTH1R and the cytoskeleton were required for these effects, because they were abolished by 1) PTH1R mutations that impair NHERF1 binding, and 2) NHERF1 mutations that impair binding to the PTH1R or the cytoskeleton. NHERF1 reduced significantly the diffusion of the PTH1R by a mechanism that was also dependent on a direct association of NHERF1 with the PTH1R and the cytoskeleton. NHERF1 increased ligand-dependent production of cAMP and induced ligand-dependent rises in intracellular calcium. These effects on calcium were due to increased calcium uptake, as they were blocked by calcium channel inhibitors and by the addition of EGTA to the medium. These calcium effects were abolished by protein kinase A inhibition but phospholipase C inhibition was without effect. Based on these analyses, we propose that, in ROS cells, the presence of NHERF1 induces PTH-dependent calcium signaling by a cAMP-mediated mechanism that involves local protein kinase A-dependent activation of calcium channels.